Sep 25, 2026•1 min read
FDA Approves ANDA 076768 for Alendronate Sodium Tablets
The FDA has granted approval for an Abbreviated New Drug Application (ANDA) 076768 covering multiple strengths of alendronate sodium tablets, manufactured by Exelan Pharmaceuticals and Cipla USA.